Cargando…
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
PURPOSE: This phase I trial aimed to assess the safety and determine the recommended Phase II dose (RP2D) of Cidofovir combined with chemoradiotherapy in patients with stage IB2-IVA cervical cancer. EXPERIMENTAL DESIGN: Incremental doses (1, 2.5, 5 and 6.5 mg/kg) of IV Cidofovir were administered we...
Autores principales: | Deutsch, Eric, Haie-Meder, Christine, Bayar, Mohamed Amine, Mondini, Michele, Laporte, Mélanie, Mazeron, Renaud, Adam, Julien, Varga, Andrea, Vassal, Gilles, Magné, Nicolas, Chargari, Cyrus, Lanoy, Emilie, Pautier, Patricia, Levy, Antonin, Soria, Jean-Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041925/ https://www.ncbi.nlm.nih.gov/pubmed/27016411 http://dx.doi.org/10.18632/oncotarget.8224 |
Ejemplares similares
-
Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?
por: Escande, Alexandre, et al.
Publicado: (2016) -
Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019) -
Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
por: Escande, Alexandre, et al.
Publicado: (2020) -
Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy
por: Holub, Katarzyna, et al.
Publicado: (2020) -
Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy
por: Bockel, Sophie, et al.
Publicado: (2019)